These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22672937)

  • 1. Decreased efficiency of MSH6 mRNA polyadenylation linked to a 20-base-pair duplication in Lynch syndrome families.
    Decorsière A; Toulas C; Fouque F; Tilkin-Mariamé AF; Selves J; Guimbaud R; Chipoulet E; Delmas C; Rey JM; Pujol P; Favre G; Millevoi S; Vagner S
    Cell Cycle; 2012 Jul; 11(13):2578-80. PubMed ID: 22672937
    [No Abstract]   [Full Text] [Related]  

  • 2. MSH6 mutations are frequent in hereditary nonpolyposis colorectal cancer families with normal pMSH6 expression as detected by immunohistochemistry.
    Okkels H; Lindorff-Larsen K; Thorlasius-Ussing O; Vyberg M; Lindebjerg J; Sunde L; Bernstein I; Klarskov L; Holck S; Krarup HB
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):470-7. PubMed ID: 22495361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of choroid plexus carcinoma that led to the diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Zhu VW; Hinduja S; Knezevich SR; Silveira WR; DeLozier CD
    Clin Neurol Neurosurg; 2017 Jul; 158():46-48. PubMed ID: 28460341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.
    Renkonen E; Zhang Y; Lohi H; Salovaara R; Abdel-Rahman WM; Nilbert M; Aittomaki K; Jarvinen HJ; Mecklin JP; Lindblom A; Peltomaki P
    J Clin Oncol; 2003 Oct; 21(19):3629-37. PubMed ID: 14512394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PMS2 involvement in patients suspected of Lynch syndrome.
    Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
    Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSH6 germline mutations are rare in colorectal cancer families.
    Peterlongo P; Nafa K; Lerman GS; Glogowski E; Shia J; Ye TZ; Markowitz AJ; Guillem JG; Kolachana P; Boyd JA; Offit K; Ellis NA
    Int J Cancer; 2003 Nov; 107(4):571-9. PubMed ID: 14520694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.
    Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N
    Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Family Affected by Lynch Syndrome Caused by MSH6 Germline Mutation].
    Chika N; Kumamoto K; Suzuki O; Fukuchi M; Matsuzawa T; Kumagai Y; Ishibashi K; Eguchi H; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2211-4. PubMed ID: 26805314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
    Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N
    Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the lower uterine segment diagnosed with Lynch syndrome based on MSH6 germline mutation: A case report.
    Adachi M; Banno K; Masuda K; Yanokura M; Iijima M; Takeda T; Kunitomi H; Kobayashi Y; Yamagami W; Hirasawa A; Kameyama K; Sugano K; Aoki D
    J Obstet Gynaecol Res; 2017 Feb; 43(2):416-420. PubMed ID: 27928858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting.
    Ramsoekh D; Wagner A; van Leerdam ME; Dinjens WN; Steyerberg EW; Halley DJ; Kuipers EJ; Dooijes D
    Gut; 2008 Nov; 57(11):1539-44. PubMed ID: 18625694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Germline mutations of the MSH6 gene in patients with an atypical hereditary nonpolyposis colorectal carcinoma (HNPCC)].
    Trojan J; Raedle J; Zeuzem S
    Z Gastroenterol; 2000 Jul; 38(7):607-9. PubMed ID: 10965560
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.
    Vilar E; Mork ME; Cuddy A; Borras E; Bannon SA; Taggart MW; Ying J; Broaddus RR; Luthra R; Rodriguez-Bigas MA; Lynch PM; You YQ
    Cancer Genet; 2014; 207(10-12):495-502. PubMed ID: 25432668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lynch syndrome in young-onset colorectal cancer: reassessing the role of the MSH6 gene.
    Giráldez MD; Castells A; Castellví-Bel S
    Clin Gastroenterol Hepatol; 2011 Sep; 9(9):806. PubMed ID: 21515405
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.
    Cederquist K; Emanuelsson M; Wiklund F; Golovleva I; Palmqvist R; Grönberg H
    Clin Genet; 2005 Dec; 68(6):533-41. PubMed ID: 16283884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare MSH2 mutation causes defective binding to hMSH6, normal hMSH2 staining, and loss of hMSH6 at advanced cancer stage.
    Loconte DC; Patruno M; Lastella P; Di Gregorio C; Grossi V; Forte G; Ingravallo G; Varvara D; Bagnulo R; Simone C; Resta N; Stella A
    Hum Pathol; 2014 Oct; 45(10):2162-7. PubMed ID: 25106712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.